Current treatment for acute viral bronchiolitis in infants

Bibliography

• EVERARD ML: Acute Bronchiolitis and pneumonia in infancy resulting from respiratory syncytial virus. In: Pediatric Respic Med. Taussig LM, Landau LI (Eds), Mosby, St Louis, USA (1999):580–595.
   Google Scholar
• •A thorough review of bronchiolitis.
   Google Scholar
• PANITCH HB: Bronchiolitis in infants. Curr. Opin. Pediatr. (2001) 13:256–260.
   PubMed Web of Science ®Google Scholar
• Sindrome de obstrucción bronquial en la infancia. Grupo De Trabajo Para El Estudio De La Enfermedad Asmática En El Nino. Ann. Esp. Ped. (2002) 56:1–60.
   Google Scholar
• HALL CB, HALL WJ, SPEERS DM: Clinical and physiological manifestations of bronchiolitis and pneumonia. Outcome of respiratory syncytial virus. Am. I Dis. Child. (1979) 133:798–802.
   PubMedGoogle Scholar
• EVERARD ML: Bronchiolitis: Origins andoptimal management. Drugs (1995) 49:885–896.
   PubMedGoogle Scholar
• KIMPEN JL, SCHAAD UB: Treatment ofrespiratory syncytial virus bronchiolitis:1995 poll of members of the European Society for Paediatric Infectious Diseases:Pediatr. Infect. Dis. J. (1997) 16:479–481.
   Google Scholar
• LUGO RA, NAHATA MC: Pathogenesis and treatment of bronchiolitis: Clin. Pharm. (1993) 12:95–116.
   Google Scholar
• MAKELA MJ, RUUSKANEN 0, OGRA PL: Treatment of respiratory syncytial virus infections in children: Ann. Med. (1994) 26:341–343.
   Google Scholar
• SIMOES EA: Respiratory syncytial virus infection: Lancet. (1999) 354:847–852.
   Google Scholar
• •An excellent comprehensive review on RSV infection, including immunopathogenetic issues and its relationship with childhood asthma.
   Google Scholar
• BLACK CP: Systematic review of the biology and medical management of respiratory syncytial virus infection. Respir. Care. (2003) 48:209–233.
   PubMedGoogle Scholar
• JARTTI T, VAN DEN HOOGEN B, GAROFALO RP, OSTERHAUS AD, RUUSKANEN 0: Metapneumovirus and acute wheezing in children: Lancet (2002) 360:1393–1394.
   Google Scholar
• BOIVIN G, DE SERRES G, COTE S et al.: Human metapneumovirus infections in hospitalized children. Emeig. Infect. Dis. (2003) 9:634–640.
   PubMed Web of Science ®Google Scholar
• WALSH EE, MCCONNOCHIE KM, LONG CE, HALL CB: Severity of respiratory syncytial virus infection is related to virus strain: Infect. Dis. (1997) 175:814–820.
   Google Scholar
• HALL CB: Respiratory syncytial virus and parainfluenza virus: New Engl. I Med. (2001) 344:1917–1928.
   Google Scholar
• MEISSNER HC: Selected populations at increased risk from respiratory syncytial virus infection: Pediatr. Infect. Dis. .1 (2003) 22:S40–S44.
   Google Scholar
• •A review of risk factors linked to the development of more severe RSV disease and for contracting RSV infection during the first year of life.
   Google Scholar
• MEISSNER HC, GROOTHUIS JR: Immunoprophylaxis and the control of RSV disease. Pediatrics (1997) 100:260–263.
   PubMed Web of Science ®Google Scholar
• CARLSEN KH, LARSEN S, BJERVE 0, LEEGAARD J: Acute bronchiolitis: predisposing factors and characterization of infants at risk. Pediatr. Pulmonol (1987) 3:153–160.
   PubMedGoogle Scholar
• WEISMAN LE: Populations at risk for developing respiratory syncytial virus and risk factors for respiratory syncytial virus severity: infants with predisposing conditions. Pediatr. Infect. Dis. 1 (2003) 22:S33–S37.
   Google Scholar
• WANG EE, LAW BJ, BOUCHER FD et al Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. Pediatr (1996) 129:390–395.
   Google Scholar
• WANG EE, LAW BJ, STEPHENS D: Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) prospective study of risk factors and outcomes in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. Pediatr (1995) 126:212–219.
   Google Scholar
• SHAY DK, HOLMAN RC, ROOSEVELT GE, CLARKE MJ, ANDERSON LJ: Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J. Infect. Dis. (2001) 183:16–22.
   PubMed Web of Science ®Google Scholar
• •An assessment of the contribution of bronchiolitis to paediatric mortality and an estimation of the number of RSV-associated deaths among US children during the years 1979-1997.
   Google Scholar
• HOLMAN RC, SHAY DK, CURNS AT, LINGAPPA JR, ANDERSON LJ: Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr. Infect. Dis. J. (2003) 22:483–490.
   PubMed Web of Science ®Google Scholar
• STANG P, BRANDENBURG N, CARTER B: The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalizations. Arch. Pediatr. Adolesc. Med. (2001) 155:95–96.
   PubMed Web of Science ®Google Scholar
• GONZALEZ CABALLERO D, GONZALEZ PEREZ-YARZA E: [Acute bronchiolitis: fundamentals of a rational protocol]. An. Esp. Pediatr. (2001) 55:355–364.
   PubMedGoogle Scholar
• STAGNARA J, BALAGNY E, COSSALTER B et al: [Management of bronchiolitis in the infant: Recommendations. Long text]. Arch. Pediatr. (2001) 8\(Suppl. 1):11–23.
   Google Scholar
• ••A French consensus clinical practiceguideline following evidence-based medicine strategy. An outstanding updated and comprehensive review of all the management issues of acute bronchiolitis.
   Google Scholar
• MARTINON-TORRES F, RODRIGUEZ NUNEZ A, MARTINON SANCHEZ JM. [Acute bronchiolitis: evidence-based therapy]. An. Esp. Pediatr (2001) 55:345–354.
   PubMedGoogle Scholar
• OUT WATER KM, CRONE RK: Management of respiratory failure in infants with acute viral bronchiolitis. Am. .1 Dis. Child. (1984) 138:1071–1075.
   PubMedGoogle Scholar
• WRIGHT RB, POMERANTZ WJ, LURIA JW: New approaches to respiratory infections in children: bronchiolitis and croup. Emerg. Med. Clin. North. Am. (2002) 20:93–114.
   PubMedGoogle Scholar
• JAFRI HS: Role of chemokines in respiratory syncytial virus disease. Pediatr. Infect. Dis. (2002) 21:454–456.
   Google Scholar
• WRIGHT PF, GRUBER WC, PETERS M et al.: Illness severity, viral shedding, and antibody responses in infants hospitalized with bronchiolitis caused by respiratory syncytial virus. Infect. Dis. (2002) 185:1011–1018.
   Google Scholar
• BONT L, KIMPEN JL: Immunological mechanisms of severe respiratory syncytial virus bronchiolitis. Intensive. Care. Med. (2002) 28:616–621.
   PubMed Web of Science ®Google Scholar
• COLBY TV: Bronchiolitis. Pathologic considerations. Am. Clin. Pathol (1998) 109:101–109.
   Google Scholar
• POPPER HH: Bronchiolitis, an update. Virchows. Arch. (2000) 437:471–481.
   PubMedGoogle Scholar
• MALLORY MD, SHAY DK, GARRETT J, BORDLEY WC: Bronchiolits management preferences and the influence of pulse oximetry and respiratory rate on the decision to admit. Pediatrics (2003) 111:e45–e51.
   Google Scholar
• REYNOLDS EOR: Arterial blood gas tensions in acute disease of lower respiratory tract infections. Br. Med. .1 (1963) 2:1192–1195.
   Google Scholar
• GARZON L, WILES L: Management ofrespiratory syncytial virus with lower respiratory tract infection in infants and children. AACN. Gin. Issues (2002) 13:421–430.
   PubMedGoogle Scholar
• SIMPSON H, MATTHEW DJ, INGLIS JM, GEORGE EL: Virological findings and blood gas tensions in acute lower respiratory tract infections in children. Br. Med. (1964) 2:629–632.
   Google Scholar
• MYERS TR: AARC Clinical Practice Guideline: selection of an oxygen delivery device for neonatal and pediatric patients-2002 revision & update. Respic Care. (2002) 47:707–716.
   PubMedGoogle Scholar
• RODRIGUEZ NUNEZ A, MARTINON SANCHEZ JM, MARTINON-TORRES F: [Medicinal gases: oxygen and heliox] An. Pediatr. Marcell (2003) 59:74–79.
   Google Scholar
• SOONG WJ, HWANG B, TANG RB: Continuous positive airway pressure by nasal prongs in bronchiolitis. Pediatr. Pulmonol (1993) 16:163–166.
   PubMed Web of Science ®Google Scholar
• BEASLEY JM, JONES SE: Continuous positive airway pressure in bronchiolitis. Br. Med. I (Clin. Res. Ed.) (1981) 283:1506–1508.
   PubMedGoogle Scholar
• FRANKEL LR, LEWISTON NJ, SMITH DW, STEVENSON DK: Clinical observations on mechanical ventilation for respiratory failure in bronchiolitis. Pediatr. Pulmonol (1986) 2:307–311.
   PubMedGoogle Scholar
• LECLERC F, SCALFARO P, NOIZET 0 et al.: Mechanical ventilatory support in infants with respiratory syncytial virus infection. Pediatr. Crit. Care. Med. (2001) 2:197–204.
   Google Scholar
• NEWTH CJ: Time course of severe respiratory syncytial virus infection in mechanically ventilated infants. Acta Paediati: (2000) 89:893–895.
   PubMedGoogle Scholar
• HAMMER J, NUMA A, and NEWTH CJ: Acute respiratory distress syndrome caused by respiratory syncytial virus. Pediatr. Pulmonol (1997) 23:176–183.
   PubMedGoogle Scholar
• MARTINON-TORRES F, RODRIGUEZ NUNEZ A, JAIMOVICH DG, MARTINON SANCHEZ JM: [High-frequency oscillatory ventilation in pediatric patients. protocol and preliminary results]. An. Esp. Pediatr (2000) 53:305–313.
   PubMedGoogle Scholar
• DUVAL EL, LEROY PL, GEMKE RJ, VAN VUGHT AJ: High-frequency oscillatory ventilation in RSV bronchiolitis patients. Respir. Med. (1999) 93:435–440.
   PubMed Web of Science ®Google Scholar
• KHAN JY, KERR SJ, TOMETZKI A et al: Role of ECMO in the treatment of respiratory syncytial virus bronchiolitis: a collaborative report. Arch. Dis. Child. Fetal. Neonatal. Ed (1995) 73:F91–F94.
   Google Scholar
• MOLER FW, PALMISANO JM, GREEN TP, CUSTER JR: Predictors of outcome of severe respiratory syncytial virus-associated respiratory failure treated with extracorporeal membrane oxygenation. Pediatr.(1993)123:46–52.
   Google Scholar
• STEINHORN RH, GREEN TP: Use of extracorporeal membran oxygenation in the treatment of respiratory syncytial virus bronchiolitis: the national experience, 1983-1988. Pediatr. (1990)116:338–342.
   Google Scholar
• MEYER TA, WARNER BW: Extracorporeal life support for the treatment of viral pneumonia: collective experience from the ELSO registry. Extracorporeal Life Support Organization. j. Pediatr. Surg. (1997) 32:232–236.
   Google Scholar
• LABBE A: Bronchiolitis in infants. Whatare the general care measures? Arch. Pediatr. (2001) 8\(Suppl. 1):935–945.
   Google Scholar
• VAN STEENSEL-MOLL HA, HAZELZET JA, VAN DER VOORT E, NEIJENS HJ, HACKENG WH: Excessive secretion on antidiuretic hormone in infections with Respiratory syncytial virus. Arch. Dis. Child.(1990) 65:1237–1239.
   PubMed Web of Science ®Google Scholar
• PINNINGTON LL, SMITH CM, ELLIS RE, MORTON RE: Feeding efficiency and respiratory integration in infants with acute viral bronchiolitis. Pediatr. (2000) 137:523–526.
   Google Scholar
• KHOSHOO V, EDELL D: Previously healthy infants may have increased risk of aspiration during respiratory syncytial viral bronchiolitis. Pediatrics (1999) 104:1389–1390.
   PubMedGoogle Scholar
• HERNANDEZ E, KHOSHOO V, THOPPIL D, EDELL D, ROSS G: Aspiration: a factor in rapidly deteriorating bronchiolitis in previously healthy infants? Pediatr. Pulmonol (2002) 33:30–31.
   PubMedGoogle Scholar
• KHOSHOO V, ROSS G, KELLY B, EDELL D, BROWN S: Benefits of thickened feeds in previously healthy infants with respiratory syncytial viral bronchiolitis. Pediatr. Pulmonol (2001) 31:301–302.
   PubMedGoogle Scholar
• HALL CB, POWELL KR, SCHNABEL KC,GALA CL, PINCUS PH: Risk of secondary bacterial infection in infants hospitalized with respiratory syncytial viral infection. I Pediatr. (1988) 113:266–271.
   Google Scholar
• KUPPERMANN N, BANK DE, WALTON EA, SENAC MO Jr, MCCASLIN I: Risks for bacteremia and urinary tract infections in young febrile children with bronchiolitis. Arch. Pediatr. Adolesc. Med. (1997) 151:1207–1214.
   PubMedGoogle Scholar
• DAVIES HD, MATLOW A, PETRIC M, GLAZIER R, WANG EE: Prospective comparative study of viral, bacterial and atypical organisms identified in pneumonia and bronchiolitis in hospitalized Canadian infants. Pediatr. Infect. Dis. J. (1996) 15:371–375.
   PubMedGoogle Scholar
• FRITS B, ANDERSEN P, BRENOE E et al.: Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. Arch. Dis. Child (1984) 59:1038–1045.
   PubMedGoogle Scholar
• LABBE A: [Bronchiolitis in infants. Antibiotics and antivirals]. Arch. Pediatr. (2001) 8\(Suppl. 1):955–975.
   Google Scholar
• FIELD CM, CONNOLLY JH, MURTAGH G, SLATTERY CM, TURKINGTON EE: Antibiotic treatment of epidemic bronchiolitis - a double-blind trial. Br. Med. J. (1966) 5479:83–85.
   Google Scholar
• PURCELL K, FERGIE J: Concurrent serious bacterial infections in 2396 infants and children hospitalized with respiratory syncytial virus lower respiratory tract infections. Arch. Pediatr. Adolesc. Med. (2002) 156:322–324.
   PubMedGoogle Scholar
• HENDERSON M, RUBIN E: Misuse of antimicrobials in children with asthma and bronchiolitis: a review. Pediatr. Infect. Dis. (2001) 20:214–215.
   Google Scholar
• KUPPERMANN N, BANK DE, WALTON EA, SENAC MO Jr, MCCASLIN I: Risks for bacteremia and urinary tract infections in young febrile children with bronchiolitis. Arch. Pediatr. Adolesc. Med. (1997) 151:1207–1214.
   PubMedGoogle Scholar
• ANTONOW JA, HANSEN K, MCKINSTRY CA, BYINGTON CL: Sepsis evaluations in hospitalized infants with bronchiolitis. Pediatr. Infect. Dis. I (1998) 17:231–236.
   PubMedGoogle Scholar
• SAMSON L, COOKE C, MACDONALD N: Analysis of antibiotic use and misuse in children hospitalized with RSV infection. Paediatr. Child Health. (1999) 4:195–199.
   PubMedGoogle Scholar
• ADCOCK PM, SANDERS CL, MARSHALL GS: Standardizing the care of bronchiolitis. Arch. Pediatr. Adolesc Med. (1998) 152:739–744.
   PubMed Web of Science ®Google Scholar
• JAFRI HS: Treatment of respiratory syncytial virus: antiviral therapies. Pediatr. Infect. Dis. 1 (2003) 22 (Suppl.):S89–S93.
   Google Scholar
• RANDOLPH AG, WANG EEL: Ribavirin for respiratory syncytial virus lower respiratory tract infection. The Cochrane Library, Issue 1 (2003) Oxford: Update Software.
   Google Scholar
• •A systematic review showing the lack of evidence to support the use of ribavirin in RSV bronchiolitis patients.
   Google Scholar
• BARRY W, COCKBURN F, CORNALL R et al.: Ribavirin aerosol for acute bronchiolitis. Arch. Dis. Child. (1986) 61:593–597.
   PubMedGoogle Scholar
• GROOTHUIS JR, WOODIN KA, KATZ R et al. Early ribavirin treatment of respiratory syncytial viral infection in high- risk children. I Pediatr. (1990) 117:792–798.
   Google Scholar
• SMITH DW, FRANKEL LR, MATHERS LH et al.: A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection. N Engl. I Med. (1991) 325:24–29.
   PubMed Web of Science ®Google Scholar
• JOHNSON EM: Developmental toxicity and safety evaluations of ribavirin. Pediatr. Infect. Dis. I (1990) 9:S85–S87.
   Google Scholar
• Reassessment of the indication for ribavirin therapy and respiratoy syncytial virus infections. American Academy of Paediatrics Committee on Infectious Diseases. Pediatrics (1996) 97:137–140.
   PubMedGoogle Scholar
• GUERGUERIAN AM, GAUTHIER M, LEBEL MH, FARRELL CA, LACROIX J: Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial. Am. I Respic Crit. Care. Med. (1999) 160:829–834.
   PubMed Web of Science ®Google Scholar
• OHMIT SE, MOLER FW, MONTO AS, KHAN AS: Ribavirin utilization and clinical effectiveness in children hospitalized with respiratory syncytial virus infection. Clin. Epidemiol (1996) 49:963–967.
   PubMed Web of Science ®Google Scholar
• MOLER FW, STEINHART CM, OHMIT SE et al.: Effectiveness of ribavirin in otherwise well infants with respiratory syncytial virus-associated respiratory failure. Pediatr. (1996) 128:422–428.
   Google Scholar
• LAW BJ, WANG EE, MACDONALD N et al.: Does ribavirin impact on the hospital course of children with respiratory syncytial virus (RSV) infection? An analysis using the pediatric investigators collaborative network on infections in Canada (PICNIC) RSV database. Pediatrics. (1997) 99:E7.
   PubMed Web of Science ®Google Scholar
• MEERT KL, SARNAIK AP, GELMINI MJ, LIEH-LAI MW: Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial. Crit. Care Med. (1994) 22:566–572.
   PubMed Web of Science ®Google Scholar
• EDELL D, KHOSHOO V, ROSS G, SALTER K: Early ribavirin treatment of bronchiolitis. Effect on long-term respiratory morbidity. Chest (2002) 122:935–939.
   Google Scholar
• KRILOV LR, MANDEL FS, BARONE SR,FAGIN JC: Follow-up of children with respiratory syncytial virus bronchiolitis in 1986 and 1987: potential effect of ribavirin on long term pulmonary function. The Bronchiolitis Study Group. Pediatr. Infect. Dis. J. (1997) 16:273–276.
   PubMed Web of Science ®Google Scholar
• LONG CE, VOTER KZ, BARKER WH, HALL CB: Long term follow-up of children hospitalized with respiratory syncytial virus lower respiratory tract infection and randomly treated with ribavirin or placebo. Pediatr. Infect. Dis. J(1997) 16:1023–1028.
   PubMed Web of Science ®Google Scholar
• ENGLUND JA, PIEDRA PA, AHN YM, GILBERT BE, HIATT P: High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection. J. Pediatr. (1994) 125:635–641.
   PubMed Web of Science ®Google Scholar
• RIMENSBERGER PC, BUREK-KOZLOWSKA A, MORELL A et al.: Aerosolized immunoglobulin treatment of respiratory syncytial virus infection in infants. Pediatr. Infect. Dis. J. (1996) 15:209–216.
   PubMedGoogle Scholar
• HEMMING VG, RODRIGUEZ W, KIM HW et at. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children. Antimicrob. Agents Chemother. (1987) 31:1882–1886.
   Google Scholar
• DEVINCENZO JP, HIRSCH RL, FUENTES RJ, TOP FH Jr: Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience. Bone. Marrow Transplant (2000) 25:161–165.
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ WJ, GRUBER WC, GROOTHUIS JR et al.: Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. Pediatrics (1997) 100:937–942.
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ WJ, GRUBER WC, WELLIVER RC et at. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group. Pediatrics. (1997) 99:454–461.
   Google Scholar
• KRILOV LR: Palivizumab in the prevention of respiratory syncytial virus disease. Expert Opin. Bio. Ther. (2002) 2:763–769.
   PubMed Web of Science ®Google Scholar
• MALLEY R, DEVINCENZO J, RAMILO 0 et al Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J. Infect. Dis. (1998) 178:1555–1561.
   PubMed Web of Science ®Google Scholar
• PRINCE GA, MATHEWS, CURTIS SJ, PORTER DD: Treatment of respiratory syncytial virus bronchiolitis and pneumonia in a cotton rat model with sistemically administered monoclonal antibody (Palivizumab) and glucocortiscosteroid. J. Infect. Dis. (2000) 182:1326–1330.
   Web of Science ®Google Scholar
• ENGLUND JA, PIEDRA PA, and WHIMBEY E: Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients. Am.J Med. (1997) 102:61–70.
   PubMedGoogle Scholar
• CONNOLLY JH, FIELD CM, GLASGOW JF, SLATTERY CM, MACLYNN DM: A double blind trial of prednisolone in epidemic bronchiolitis due to respiratory syncytial virus. Acta. Paediatr. Scand. (1969) 58:116–120.
   PubMedGoogle Scholar
• DE BOECK K, VAN DER AA N, VAN LIERDE S, CORBEEL L, EECKELS R: Respiratory syncytial virus bronchiolitis: a double-blind dexamethasone efficacy study. Pediatr. (1997) 131:919–921.
   Google Scholar
• RICHTER H, SEDDON P: Early nebulized budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing. Pediatr (1998) 132:849–853.
   Google Scholar
• CADE A, BROWNLEE KG, CONWAY SP et al. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch. Dis. Child (2000) 82:126–130.
   PubMed Web of Science ®Google Scholar
• BULOW SM, NIR M, LEVIN E et al: Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics. (1999) 104:e77.
   PubMed Web of Science ®Google Scholar
• LEER JA Jr, GREEN JL, HEIMLICH EM et al.: Corticosteroid treatment in bronchiolitis. A controlled, collaborative study in 297 infants and children. Ain. J. Dis. Child. (1969) 117:495–503.
   Google Scholar
• TAL A, BAVILSKI C, YOHAI D et al: Dexamethasone and salbutamol in the treatment of acute wheezing in infants. Pediatrics. (1983) 71:13–18.
   PubMed Web of Science ®Google Scholar
• WONG JY, MOONS, BEARDSMORE C, O'CALLAGHAN C, SIMPSON H: No objective benefit from steroids inhaled via a spacer in infants recovering from bronchiolitis. Ear: Respir. (2000) 15:388–394.
   PubMed Web of Science ®Google Scholar
• BERGER I, ARGAMAN Z, SCHWARTZ SB et al: Efficacy of corticosteroids in acute bronchiolitis: short-term and long-term follow-up. Pediatr. Pulmonol (1998) 26:162–166.
   PubMed Web of Science ®Google Scholar
• ROOSEVELT G, SHEEHAN K, GRUPP-PHELAN J, TANZ RR, LISTERNICK R: Dexamethasone in bronchiolitis: a randomised controlled trial. Lancet (1996) 348:292–295.
   PubMed Web of Science ®Google Scholar
• KLASSEN TP, SUTCLIFFE T, WATTERS LK et al.: Dexamethasone in salbutamol-treated inpatients with acute bronchiolitis: a randomized, controlled trial. I. Pedian:(1997) 130(2):191–196.
   Google Scholar
• LIPWORTH BJ: Systemic adverse effects of inhaled corticosteroid therapy: a systematic review and meta-analysis. Arch. Intern. Med. (1999) 159:941–955.
   PubMed Web of Science ®Google Scholar
• ALLEN DB, MULLEN M, MULLEN B: A meta-analysis of the effect of oral and inhaled corticosteroids on growth. I Allergy Clin. Immunol (1994) 93:967–976.
   PubMed Web of Science ®Google Scholar
• GARRISON MM, CHRISTAKIS DA, HARVEY E, CUMMINGS P, DAVIS RL: Systemic corticosteroids in infant bronchiolitis: a meta-analysis. Pediatrics (2000) 105:E44.
   PubMed Web of Science ®Google Scholar
• •The latest meta-analysis on the utility of corticosteroids in the treatment of RSV bronchiolitis including six randomised controlled trials. The overall improvement detected with its use is no longer present when recurrent whezeers are excluded from the analysis.
   Google Scholar
• VAN WOENSEL JB, VAN AALDEREN WM, DE WEERD W et al.: Dexamethasone for treatment ofpatients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus. Thorax (2003) 58:383–387.
   Google Scholar
• SCHUH S, COATES AL, BINNIE R et al.: Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. .1. Pediatr. (2002)140:27–32.
   Google Scholar
• ••An exciting new trial on corticosteroidtherapy in bronchiolitis patients showing striking differences with the results of other previously published trials. Further studies seem necessary before this strategy is incorporated into routine practice.
   Google Scholar
• MCBRIDE JT: Dexamethasone and bronchiolitis: a new look at an old therapy? .1. Pediatr (2002)140:8–9.
   Google Scholar
• POSTIAUX G: [Bronchiolitis in infants. What are the techniques of bronchial and upper airway respiratory therapy adapted to infanta Arch. Pediatr. (2001) 8\(Suppl. 1):1175–1255.
   Google Scholar
• •An essential review to understand the differences between french-speaking and english-speaking ways of interpreting respiratory physiotherapy, in general terms and in bronchiolitis patients.
   Google Scholar
• PORTER AL: Physiotherapy in the treatment of bronchiolitis and broncho-pneumonia in babies and young children. Physiotherapy (1967) 53:333–335.
   PubMedGoogle Scholar
• WEBB MS, MARTIN JA, CARTLIDGE PH, NG YK, WRIGHT NA: Chest physiotherapy in acute bronchiolitis. Arch. Dis. Child. (1985) 60:1078–1079.
   PubMed Web of Science ®Google Scholar
• VIVIANO GG, REALE A, IANNELLI M: Validity and limitations of respiratory physiotherapy in children. Pediatr. Med. Chir (1990) 12:155–156.
   PubMedGoogle Scholar
• QUITTELL LM, WOLFSON MR, SCHIDLOW DV: The effectiveness of chest physical therapy in infants with bronchiolitis. Am. Rev RespirDis (1988) 137:406A.
   PubMedGoogle Scholar
• NICHOLAS KJ, DHOUIEB MO, MARSHALL TG, EDMUNDS AT, GRANT MB: An evaluation of chest physiotherapy in the management of acute bronchiolitis: changing clinical practice. Phystiotherapy (1999) 85:669–674.
   Google Scholar
• OBERWALDNER B: Physiotherapy for airway clearance in paediatrics. Ear: Respir. (2000) 15:196–204.
   PubMed Web of Science ®Google Scholar
• OBERWALDNER B, ZACH MS: [Mucous clearing respiratory-physiotherapy in pediatric pneumology]. Schweiz Med. Wochenschr. (2000) 130:711–719.
   PubMedGoogle Scholar
• NASR SZ, STROUSE PJ, SOSKOLNE E et al.: Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis. Chest (2001) 120:203–208.
   PubMed Web of Science ®Google Scholar
• BOEUF B, PROUIX F, MORNEAU S, MARTON D, LACROIX J: Safety of endotracheal rh DNAse (Pulmozyme) for treatment of pulmonary atelectasis in mechanically ventilated children. Pediatr. Pulmonol (1998) 26:147.
   PubMedGoogle Scholar
• EL HASSAN NO, CHESS PR, HUYSMAN MW, MERKUS PJ, DE JONGSTE JC: Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates. Pediatrics (2001) 108:468–470.
   PubMedGoogle Scholar
• MERKUS PJ, DE HOOG M, VAN GENT R, DE JONGSTE JC: DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis. Ear: Respir J. (2001) 18:734–737.
   PubMed Web of Science ®Google Scholar
• WARK PA, MCDONALD V: Nebulised hypertonic saline for cystic fibrosis. Cochrane Database System Review (2003):CD001506.
   Google Scholar
• SARRELL EM, TAL G, WITZLING M et al.: Nebulized 3% hypertonic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms. Chest (2002) 122: 2015-2020.
   Google Scholar
• MANDELBERG A, TAL G, WITZLING M et al.: Nebulized 3% hypertonic saline solution treatment in hospitalized infants with viral bronchiolitis. Chest (2003) 123:481–487.
   PubMed Web of Science ®Google Scholar
• •The newest randomised, controlled trial on the utility of nebulised 3% hypertonic saline that shows its capability of reducing symptoms and length of stay compared to 0.9% saline solution.
   Google Scholar
• LABBE A: Bronchiolitis in infants. Mucolytics, antitussives and other drugs. Arch. Pediatr. (2001) 8\(Suppl. 1):98S–99S.
   Google Scholar
• CHALUMEAU M, TRELUYER JM, SALANAVE B et al.: Off label and unlicensed drug use among French office based paediatricians. Arch. Dis. Child (2000) 83:502–505.
   PubMed Web of Science ®Google Scholar
• GIBSON LE: Use of water vapor in the treatment of lower respiratory disease. Am. Rev Respir. Dis. (1974) 110:100–103.
   PubMed Web of Science ®Google Scholar
• SZILAGYI PG: Humidifiers and other symptomatic therapy for children with respiratory tract infections. Pediatr. Infect. Dis. J. (1991) 10:478–479.
   PubMedGoogle Scholar
• TAUSSIG LM: Editorial: mists and aerosols: new studies, new thoughts. Pediatr. (1974) 84:610–622.
   Google Scholar
• CLEMENS CJ, TAYLOR JA, ALMQUIST JR et al.: Is an antihistamine-decongestant combination effective in temporarily relieving symptoms of the common cold in preschool children? Pediatr. (1997) 130:463–466.
   Google Scholar
• American academy of pediatrics committee on drugs. Use of codeine- and dextromethorphan-containing cough syrups in pediatrics. Pediatrics (1978) 62:118–122.
   PubMed Web of Science ®Google Scholar
• Use of codeine- and dextromethorphan-containing cough syrups in children. American academy of pediatrics committee on durgs. Pediatrics (1997) 6:918–920.
   Google Scholar
• KERNAN WN, VISCOLI CM, BRASS LM et al. Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl. Med. (2000) 343:1826–1832.
   PubMed Web of Science ®Google Scholar
• RODRIGUEZ NUNEZ A, MARTINON-TORRES F, MARTINON SANCHEZ JM: Application of corticosteroids and bronchodilators in infants with bronchiolitis. An. Esp. Pediatr. (1999) 128\(Suppl. 1):524–526.
   Google Scholar
• KELLNER JD, OHLSSON A, GAD OMSKI AM, WANG EEL: Bronchodilators for bronchiolitis. The Cochrane Library, Issue 1 (2003). Oxford: Update Software.
   Google Scholar
• •The latest systematic review on bronchodilators value in bronchiolitis. Includes all the methodological considerations for accepting or rejecting published studies, and a cost-analysis for routine use of bronchodilators.
   Google Scholar
• FLORES G, HORWITZ RI. Efficacy of 132-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics (1997) 100:233–239.
   PubMed Web of Science ®Google Scholar
• GAD OMSKI AM, LICHENSTEIN R, HORTON L et al.: Efficacy of albuterol in the management of bronchiolitis. Pediatrics (1994) 93:907–912.
   PubMedGoogle Scholar
• HO L, COLLIS G, LANDAU LI, LE SOUEF PN: Effect of salbutamol on oxygen saturation in bronchiolitis. Arch. Dis. Child (1991) 66:1061–1064.
   PubMed Web of Science ®Google Scholar
• O'CALLAGHAN C, MILNER AD, SWARBRICK A: Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet (1986) 2:1424–1425.
   PubMed Web of Science ®Google Scholar
• PRENDIVILLE A, GREEN S, SILVERMAN M: Paradoxical response to nebulised salbutamol in wheezy infants, assessed by partial expiratory flow-volume curves. Thorax (1987) 42:86–91.
   PubMed Web of Science ®Google Scholar
• LUGO RA, SALYER JW, DEAN JM: Albuterol in acute bronchiolitis-continued therapy despite poor response? Pharmacutherapy (1998) 18:198–202.
   PubMedGoogle Scholar
• BARR FE, PATEL N, NEWTH CJL: The pharmacologic mechanism by which inhaled epinephrine reduces airway obstruction in respiratory syncitial virus associated bronchiolitis. Pediatr. (2000) 136:699–700.
   Google Scholar
• KRISTJANSSON S, LODRUP CARLSEN KC, WENNERGREN G, STRANNEGARD IL, CARLSEN KH: Nebulised racemic adrenaline in the treatment of acute bronchiolitis in infants and toddlers. Arch. Dis. Child (1993) 69:650–654.
   PubMed Web of Science ®Google Scholar
• MENON K, SUTCLIFFE T, KLASSEN TP: A randomized trial comparing the efficacy of epinephrine with salbutamol in the treatment of acute bronchiolitis. J. Pediatr (1995) 126:1004–1007.
   PubMed Web of Science ®Google Scholar
• REIJONEN T, KORPPI M, PITKAKANGAS S, TENHOLA S, REMES K: The clinical efficacy of nebulized racemic epinephrine and albuterol in acute bronchiolitis. Arch. Pediatr. Adolesc. Med. (1995) 149:686–692.
   PubMed Web of Science ®Google Scholar
• •The up-to-date, most important randomised, controlled trial supporting the superiority of epinephrine to placebo or salbutamol in the therapy of infants with acute viral bronchiolitis.
   Google Scholar
• LOWELL DI, LISTER G, VON KOSS H, MCCARTHY P: Wheezing in infants: the response to epinephrine. Pediatrics (1987) 79:939–945.
   PubMed Web of Science ®Google Scholar
• BERTRAND P, ARANIBAR H, CASTRO E, SANCHEZ I: Efficacy of nebulized epinephrine versus salbutamol in hospitalized infants with bronchiolitis. Pediatr. Pulmonol (2001) 31:284–288.
   PubMed Web of Science ®Google Scholar
• SANCHEZ I, DE KOSTER J, POWELL RE, WOLSTEIN R, CHERNICK V: Effect of racemic epinephrine and salbutamol on clinical score and pulmonary mechanics in infants with bronchiolitis. J. Pediatr (1993) 122:145–151.
   PubMed Web of Science ®Google Scholar
• MARTINEZ-JIMENEZ NB, MAZA-TOLEDO AA, LOPEZ-JIMENEZ C, ORTIZ-MENDEZ V: Respuesta al tratamiento de la bronquiolitis con epinefrina natural (leveigira) inhalada. Rev Mex Pediatr (2001) 68:5–7.
   Google Scholar
• CORONEL CARVAJAL C: Natural epinephrine in bronchiolitis. Rev Esp. Pediatr. (2001) 57:497–501.
   Google Scholar
• SOM RAY M, SING V: Comparison of nebulized adrenaline versus salbutamol in wheeze associated respiratory tract infection in infants. Indian Pediatr. (2002) 39:12–22.
   PubMedGoogle Scholar
• LODRUP CARLSEN KC, CARLSEN KH: Inhaled nebulized adrenaline improves lung function in infants with acute bronchiolitis. Respic Med. (2000) 94:709–714.
   PubMed Web of Science ®Google Scholar
• NUMA AH, WILLIAMS GD, DAKIN CJ: The effect of nebulized epinephrine on respiratory mechanics and gas exchange in bronchiolits. Am. .1. Respic Crit. Care. (2001) 164:86–91.
   PubMedGoogle Scholar
• PATEL H, PLATT RW, PEKELES GS, DUCHARME FM: A randomized, controlled trial of the effectiveness of nebulized therapy with epinephrine compared with albuterol and saline in infants hospitalized for acute viral bronchiolitis. Pediatr. (2002) 141:818–824.
   Google Scholar
• MARTINON-TORRES F, RODRIGUEZ NUNEZ A, MARTINON SANCHEZ JM: Bronchiolitis and epinephrine: reviewing the evidence. An. Esp. Pediatr. (2002) 56:363–364.
   PubMedGoogle Scholar
• ABUL-AININE A, LUYT D: Short term effects of adrenaline in bronchiolitis: a randomised controlled trial. Arch. Dis. Child. (2002) 86:276–279.
   PubMedGoogle Scholar
• SCHUH S, JOHNSON D, CANNY G et al.: Efficacy of adding nebulized ipratropium bromide to nebulized albuterol therapy in acute bronchiolitis. Pediatrics (1992) 90:920–923.
   PubMedGoogle Scholar
• RUBIN BK, ALBERS GM: Use of anticholinergic bronchodilation in children. Am.' Med. (1996) 100:49S–53S.
   Google Scholar
• SEIDENBERG J, MASTERS IB, HUDSON I, OLINSKY A, PHELAN PD: Effect of ipratropium bromide on respiratory mechanics in infants with acute bronchiolitis. Aust. Paediatr. (1987) 23:169–172.
   PubMedGoogle Scholar
• HENRY RL, MILNER AD, STOKES GM: Ineffectiveness of ipratropium bromide in acute bronchiolitis. Arch. Dis. Child. (1983) 58:925–926.
   PubMed Web of Science ®Google Scholar
• SAMMARTINO LP, LINES D: Efficacy of ipratropium bromide by metered dose aerosol and aerochamber in acute paediatric bronchiolitis. I Paediatr. Child. Health. (1997) 33:459.
   PubMedGoogle Scholar
• WANG EE, MILNER R, ALLEN U, MAJ H: Bronchodilators for treatment of mild bronchiolitis: a factorial randomised trial. Arch. Dis. Child. (1992) 67:289–293.
   PubMed Web of Science ®Google Scholar
• PANITCH HB: Respiratory syncytial virus bronchiolitis: supportive care and therapies designed to overcome airway obstruction. Pediatr. Infect. Dis. (2003) 22:S83–87.
   Google Scholar
• BROOKS LJ, CROPP GJ: Theophylline therapy in bronchiolitis. A retrospective study. Am. Dis. Child (1981) 135:934–936.
   PubMedGoogle Scholar
• LABBE A, BILLET P, PAIRE M et at. Treatment of acute bronchiolitis in infants by oral suspension theophylline. Double-blind study in 62 children. Pediatrics (1985) 40:195–199.
   Google Scholar
• BARACH AL: The therapeutic use of helium. JAMA (1936)107:1273–1275.
   Google Scholar
• MARTINON-TORRES F, NUNEZ AR, MARTINON JM: Heliox: pediatric perspectives of application. An. Esp. Ped. (1999) 128\(Suppl. 1):42S–45S.
   Google Scholar
• MARTINON-TORRES F: Ventilación con helio. In: Tratado de Cuidados Intensivos Pediatricos. Ruza Tando F (Ed.), Norma Capitel, Madrid, Spain (2003):677–681.
   Google Scholar
• MANTHOUS, CA, MORGAN S, POHLMAN A, HALL JB: Heliox in the treatment of airflow obstruction: a critical review of the literature. Respic Care. (1997) 42:1034–1042.
   Google Scholar
• MYERS TR: Therapeutic gases for neonatal and pediatric respiratory care. Respic Care. (2003) 48:399–425.
   PubMedGoogle Scholar
• •A careful and updated review on the paediatric uses of therapeutic gases, including helium gas mixtures and bronchiolitis setting.
   Google Scholar
• PARET G, DEKEL B, VARDI A et al: Heliox in respiratory failure secondary to bronchiolitis: a new therapy. Pediatr. Pulmona (1996) 22:322–323.
   PubMedGoogle Scholar
• HOLLMAN G, SHEN G, ZENG L et al: Helium-oxygen improves Clinical Asthma Scores in children with acute bronchiolitis. Crit. Care. Med. (1998) 26:1731–1736.
   PubMed Web of Science ®Google Scholar
• MARTINON-TORRES F, RODRIGUEZ-NUNEZ A, MARTINON-SANCHEZ JM: Heliox therapy in infants with acute bronchiolitis. Pediatrics. (2002) 109:68–73.
   PubMed Web of Science ®Google Scholar
• GROSS ME SPEAR RM, PETERSON BM: Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchiolitis. Crit. Care. (2000) 4:188–192.
   PubMedGoogle Scholar
• PATEL NR, HAMMER J, NICHANI S, NUMA A, NEWTH CJ: Effect of inhaled nitric oxide on respiratory mechanics in ventilated infants with RSV bronchiolitis. Intensive. Care. Med. (1999) 25:81–87.
   PubMed Web of Science ®Google Scholar
• FITZGERALD D, DAVIS G, ROHLICEK C, GOTTESMAN R: Quantifying pulmonary hypertension in ventilated infants with bronchiolitis: a pilot study. J. Paediam. Child. Health (2001) 37:64–66.
   PubMedGoogle Scholar
• LECLERC F, RIOU Y, MARTINOT A et al.: Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia. Intensive. Care. Med. (1994) 20:511–512.
   PubMedGoogle Scholar
• HOEHN T, KRAUSE M, KRUEGER M, HENTSCHEL R: Treatment of respiratory failue with inhaled nitric oxide and high-frequency ventilation in an infant with respiratory syncytial virus pneumonia and bronchopulmonary dysplasia. Respiration.(1998) 65:477–480.
   PubMed Web of Science ®Google Scholar
• TIBBY SM, HATHERILL M, WRIGHT SM et al.: Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. Am. I Respic Grit. Care. Med. (2000) 162:1251–1256.
   PubMed Web of Science ®Google Scholar
• LUCHETTI M, CASIRAGHI G, VALSECCHI R, GALASSINI E, MARRARO G: Porcine-derived surfactant treatment of severe bronchiolitis. Acta Anaesthesia Scand. (1998) 42:805–810.
   PubMed Web of Science ®Google Scholar
• GREENOUGH A: Expanded use of surfactant replacement therapy. Eui: Pediatr (2000) 159:635–640.
   PubMed Web of Science ®Google Scholar
• LUCHETTI M, FERRERO F, GALLINI C et al.: Multicenter randomized, controlled study of porcine surfactant in severe respiratory syncytial virus-induced respiratory failure. Pediatr. Crit. Care. Med. (2002) 3:261–268.
   PubMedGoogle Scholar
• ISAACS D: Production of interferon in respiratory syncytial virus bronchiolitis. Arch. Dis. Child. (1989) 64:92–95.
   PubMedGoogle Scholar
• HIGGINS PG, BARROW GI, TYRRELL DA, ISAACS D, GAUCI CL: The efficacy of intranasal interferon alpha-2a in respiratory syncytial virus infection in volunteers. Antiviral. Res. (1990) 14:3–10.
   PubMedGoogle Scholar
• CHIPPS BE, SULLIVAN WE PORTNOY JM: Alpha-2A-interferon for treatment of bronchiolitis caused by respiratory syncytial virus. Pediatr. Infect. Dis. J. (1993) 12:653–658.
   PubMedGoogle Scholar
• SUNG RY, YIN J, OPPENHEIMER SJ, TAM JS, LAU J: Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a. Arch. Dis. Child. (1993) 69:440–442.
   PubMed Web of Science ®Google Scholar
• PORTNOY J, HICKS R, PACHECO F, OLSON L: Pilot study of recombinant interferon alpha-2a for treatment of infants with bronchiolitis induced by respiratory syncytial virus. Antimicrob. Agents. Chemother. (1988) 32:589–591.
   PubMedGoogle Scholar
• QUINLAN KP, HAYANI KC: Vitamin A and respiratory syncytial virus infection. Serum levels and supplementation trial. Arch. Pediatr. Adolesc. Med. (1996) 150:25–30.
   PubMedGoogle Scholar
• PINNOCK CB, DOUGLAS RM, MARTIN AJ, BADCOCK NR: Vitamin A status of children with a history of respiratory syncytial virus infection in infancy. Aust. Paediam 1 (1988) 24:286–289.
   PubMedGoogle Scholar
• NEUZIL KM, GRUBER WC, CHYTIL F et al.: Serum vitamin A levels in respiratory syncytial virus infection. J. Pediatr. (1994) 124:433–436.
   PubMed Web of Science ®Google Scholar
• DOWELL SF, PAPIC Z, BRESEE JS et al: Treatment of respiratory syncytial virus infection with vitamin A: a randomized, placebo-controlled trial in Santiago, Chile. Pediatr. Infect. Dis. J. (1996) 15:782–786.
   PubMed Web of Science ®Google Scholar
• KJOLHEDE CL, CHEW FJ, GADOMSKI AM, MARROQUIN DP: Clinical trial of vitamin A as adjuvant treatment for lower respiratory tract infections. J. Pediatr (1995) 126:807–812.
   PubMed Web of Science ®Google Scholar
• BRESEE JS, FISCHER M, DOWELL SF et al.: Vitamin A therapy for children with respiratory syncytial virus infection: a multicenter trial in the United States. Pediatr. Infect. Dis. J. (1996) 15:777–782.
   PubMed Web of Science ®Google Scholar
• WANG YH, XU KJ, JIANG WS: [Experimental and clinical study of shuanghuanglian aerosol in treating acute respiratory tract infection]. Zhongguo Zhong Xi Yffie He Za Zhi (1995) 15:347–350.
   PubMedGoogle Scholar
• KONG XT, FANG HT, JIANG GQ et al.: Treatment of acute bronchiolitis with Chinese herbs. Arch. Dis. Child. (1993) 68:468–471.
   PubMed Web of Science ®Google Scholar
• MA R: Antiviral and interferon-inducing effect of fang-gan mixture. Zhong Xi Yffie He Za Zhi (1990) 10:222–224.
   PubMedGoogle Scholar
• LIU C, DOUGLAS RM: Chinese herbal medicines in the treatment of acute respiratory infections: a review of randomised and controlled clinical trials. Med. J. Aust. (1998) 169:579–582.
   PubMedGoogle Scholar
• LIU C, DOUGLAS RM: Chinese Herbal Medicine in the treatment of acute respiratory tract infections: review of randomized and controlled clinical trials. Clin. Infect. Dis. (1999) 28:235–236.
   PubMedGoogle Scholar
• BISGAARD H: A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis. Am. .1 Respic Crit. Care. Med. (2003) 167:379–383.
   Google Scholar
• KHOSHOO V, ROSS G, EDELL D: Effect of interventions during acute respiratory syncytial virus bronchiolitis on subsequent long term respiratory morbidity. Pediatr. Infect. Dis. J. (2002) 21:468–472.
   PubMedGoogle Scholar
• NG DK, LAW AK, CHAU KW, CHAN HK: Use of montelukast in the treatment of early childhood wheezing from clinical experience with three cases. Respirology (2000) 5:389–392.
   PubMedGoogle Scholar
• SZEFLER SJ, SIMOES EA: Montelukast for respiratory syncytial virus bronchiolitis: significant effect or provocative findings? Am. I Respir. Grit. Care. Med. (2003) 167:290–291.
   PubMedGoogle Scholar
• VAN BEVER HP, DESAGER KN, PAUWELS JH, WOJCIECHOWSKI M, VERMEIRE PA: Aerosolized furosemide in wheezy infants: a negative report. Pediatr. Pulmonol (1995) 20:16–20.
   PubMed Web of Science ®Google Scholar
• YOUSSEF-AHMED MZ, SILVER P, NIMKOFF L, SAGY M: Continuous infusion of ketamine in mechanically ventilated children with refractory bronchospasm. Intensive. Care. Med. (1996) 22:972–976.
   PubMed Web of Science ®Google Scholar
• ZUNIGA A, BURDACH R, RUBIO S: Dimethyl sulfoxide therapy in bronchiolitis. Ann. NY Acad. Sci. (1975) 243:460–467.
   PubMedGoogle Scholar
• MAFFEI S, MAZZARINO I, FORENZA N et al.: First results and considerations upon treatment with heparin in bronchiolitis. Ped. Med. Chir (1986) 8:373–376.
   PubMedGoogle Scholar
• HARRISON AM, BOEING NM, DOMACHOWSKE JB, PIEDMONTE MR, KANTER RK: Effect of RSV bronchiolitis practice guidelines on resource utilization. Clin. Pediatr. (Ph/la) (2001) 40:489–495.
   PubMedGoogle Scholar
• PERLSTEIN PH, KOTAGAL UR, BOLLING C et al.: Evaluation of an evidence-based guideline for bronchiolitis. Pediatrics. (1999) 104:1334–1341.
   PubMed Web of Science ®Google Scholar
• PERLSTEIN PH, KOTAGAL UR, SCHOETTKER PJ et al.: Sustaining the implementation of an evidence-based guideline for bronchiolitis. Arch. Pediatr. Adolesc. Med. (2000) 154:1001–1007.
   PubMedGoogle Scholar
• BARBEN JU, ROBERTSON CE ROBINSON PJ: Implementation of evidence-based management of acute bronchiolitis. Paediam. Child. Health. (2000) 36:491–497.
   PubMedGoogle Scholar
• Evidence based clinical practice guideline for infant with bronchiolitis. Cincinnati (OH): Cincinnati Children's Hospital Medical Center. (2001) 28:9.
   Google Scholar
• GREENSILL J, MCNAMARA PS, DOVE W et al. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg. Infect. Dis. (2003) 9:372–375.
   PubMed Web of Science ®Google Scholar
• FREYMOUTH F, VABRET A, LEGRAND L et al.: Presence of the new human metapneumovirus in French children with bronchiolitis. Pediatr. Infect. Dis. .1. (2003) 22:92-94.
   Google Scholar
• MEISSNER HC: Selected populations at increased risk from respiratory syncytial virus infection. Pediatr. Infect. Dis. (2003) 22:S40–S44.
   Google Scholar
• HALL CB, POWELL KR, MACDONALD NE et at. Respiratory syncytial viral infection in children with compromised immune function. N Engl. J. Med. (1986) 315:77–81.
   Google Scholar
• WENDT CH, HERTZ MI: Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin. Respir. Infect. (1995) 10:224–231.
   PubMedGoogle Scholar
• HUGHES DM, LE SOUEF PN, LANDAU LI: Effect of salbutamol on respiratory mechanics in bronchiolitis. Pediatr. Res. (1987) 22:83–86.
   PubMed Web of Science ®Google Scholar
• STOKES GM, MILNER AD, HODGES IGC et al.: Nebulised therapy in acute severe bornchiolitis in infancy. Arch. Dis. Child. (1983) 58:279–282.
   PubMed Web of Science ®Google Scholar
• TIDDENS HA, HOFHUIS W, BOGAARD JM et al: Compliance, hysteresis, and collapsibility of human small airways. Am. .1. Respic Crit. Care. Med. (1999) 160:1110–1118.
   Google Scholar
• NEWTH CJ, AMSLER B, RICHARDSON BP, HAMMER J: The effects of bronchodilators on spontaneous ventilation and oxygen consumption in rhesus monkeys. Pediatr. Res. (1997) 42:157–162.
   PubMedGoogle Scholar